Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOld Mutual Lim. Regulatory News (OMU)

Share Price Information for Old Mutual Lim. (OMU)

Share Price is delayed by 15 minutes
Get Live Data
59.20    -0.80 (-1.33%)
Bid:
59.20
Ask:
59.60
Spread: 0.40 (0.676%)
Market Cap: £2.36b
OMU Live PriceLast checked at - London Stock Exchange

Intraday Old Mutual Lim. Share Chart

Trading Statement

26 Aug 2025 07:00

RNS Number : 6500W
Old Mutual Limited
26 August 2025
 

Old Mutual Limited

Incorporated in the Republic of South Africa

Registration number: 2017/235138/06

ISIN: ZAE000255360

LEI: 213800MON84ZWWPQCN47

JSE Share Code: OMU

JSE Share Code: OMLI

LSE Share Code: OMU

NSX Share Code: OMM

MSE Share Code: OMU

ZSE Share Code: OMU

("Old Mutual" or "Group")

 

Ref: 24/25

26 August 2025

 

OLD MUTUAL TRADING STATEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025

 

Investors are advised that Old Mutual is currently in the process of finalising its interim results for the six months ended 30 June 2025, which will be released on the Stock Exchange News Service of the JSE Limited on Wednesday, 10 September 2025. This trading statement provides an indication of a range for headline earnings per share and earnings per share in terms of paragraph 3.4(b) of the JSE Limited Listings Requirements compared to the six months ended 30 June 2024 (prior period).

Results from operations per share, adjusted headline earnings per share, headline earnings per share and basic earnings per share growth benefited from the share repurchase programme implemented in 2024 which contributed to a reduction in the weighted average number of ordinary shares to 4 270 million at 30 June 2025 (4 359 million at 30 June 2024).

Growth in results from operations was primarily driven by exceptional growth in Old Mutual Insure and the impact of favourable financial markets. In addition, the prior period included once off adverse mortality experience in Personal Finance and an impairment of a secured loan in Mass and Foundation Cluster. This growth was partially offset by the negative impact of a persistency basis change in Mass and Foundation Cluster and higher central costs which includes a once off restructuring provision incurred to reduce future spending.

Adjusted headline earnings growth was further bolstered by increased shareholder investment returns as a result of improved performance in the South African and Malawian equity markets which were considerably above expected returns.

Investors are reminded that we exclude the profits of our Zimbabwean business from adjusted headline earnings due to continued restrictions on accessing capital by way of dividends. The reduction in IFRS profit and headline earnings was driven by an approximately R2.2 billion decrease in the Zimbabwe profits as we implemented a change in functional currency from Zimbabwe Gold to the United States dollar from 1 July 2024. While this resulted in lower IFRS earnings to the Group, this had a limited impact on net asset value due to lower currency translation losses reflected in equity. This decrease in IFRS profits and headline earnings does not have any impact on adjusted headline earnings.

Investors are advised that the Group's key profit measures are expected to be within the ranges outlined below:

Key Performance Indicators

(R million unless stated otherwise)

 

Estimated

% change

 

Estimated

30 June 2025

Unaudited

results for the six months

ended

30 June 2024

Results from operations1

6% to 26%

4 498 to 5 346

4 243

Results from operations per share (cents)2

9% to 29%

104.1 to 123.2

95.5

Adjusted headline earnings3

19% to 39%

3 888 to 4 541

3 267

Adjusted headline earnings per share (cents)2

21% to 41%

88.9 to 103.6

73.5

Headline earnings

-39% to -19%

3 553 to 4 718

5 825

Headline earnings per share (cents)

-37% to -17%

84.2 to 110.9

133.6

IFRS profit after tax attributable to equity holders of the parent (IFRS profit)

-31% to -12%

3 616 to 4 612

5 241

Basic earnings per share (cents)

-30% to -10%

84.1 to 108.2

120.2

 

1 Results from operations is the primary measure of the operating business performance of the Group's segments

2 Results from operations per share and adjusted headline earnings per share are calculated with reference to adjusted weighted average number of shares. The weighted average number of shares is adjusted to reflect the Group's Broad-Based Black Economic Empowerment shares

3 Adjusted headline earnings is the Group's primary profit metric

 

Investor engagement

 

A webcast of the presentation of the 2025 Interim results and Q&A will be on Wednesday, 10 September 2025 at 11:00 South African time.

Register on the Investor Relations website: Investor Relations | Old Mutual

Alternatively, pre-register to participate in the call on the following link:

Diamond Pass Registration

Analysts and investors who wish to participate in the call may do so using the same link or telephone numbers below:

Access numbers for recorded playback:

Access code for recorded playback: 47891

South Africa

+27 10 500 4108

UK

+44 203 608 8021

Australia

+61 73 911 1378

USA

+1 412 317 0088

International

+27 10 500 4108

 

To access the replay using an international dial-in number, please select the link below:

https://services.choruscall.com/ccforms/replay.html

The replay will be available until 15 September 2025

 

The financial information in this trading statement is the responsibility of the Old Mutual Limited Board of Directors and has not been reviewed or reported on by the Group's external auditors.

 

Sandton

 

Sponsors

JSE

Tamela Holdings (Proprietary) Limited

Namibia

PSG Wealth Management (Namibia) (Proprietary) Limited

Zimbabwe

Imara Capital Zimbabwe plc

Malawi

Stockbrokers Malawi Limited

 

Enquiries

 

Investor Relations

 

Langa Manqele

Head of Investor Relations

 

M: +27 82 295 9840

E: investorrelations@oldmutual.com

 

Communications

Wendy Tlou M: +27 82 906 5008

Chief Communications

and Reputation Officer E: oldmutualnews@oldmutual.com

 

Notes to Editors

About Old Mutual

Old Mutual is a premium African financial services group that offers a broad spectrum of financial solutions to retail and corporate customers across key market segments in 12 countries. Old Mutual's primary operations are in Africa and it has a niche business in China. With over 180 years of heritage across sub-Saharan Africa, Old Mutual is a crucial part of the communities it serves as well as broader society on the continent.

 

For further information on Old Mutual and its underlying businesses, please visit the corporate website at www.oldmutual.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUNRVRVRUWURR
Date   Source Headline
25th Apr 20233:30 pmRNSNotice of AGM and no change statement
24th Apr 202311:00 amRNSDirector/PDMR Shareholding
21st Apr 20231:45 pmRNSForm 8.3 - [Mediclinic International plc]
19th Apr 20234:00 pmRNSDirector/PDMR Shareholding
14th Apr 202311:00 amRNSRelease of Integrated Report & Investor Engagement
13th Apr 202312:30 pmRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSForm 8.3 - [Mediclinic International plc]
6th Apr 20234:40 pmRNSDirector/PDMR Shareholding
6th Apr 20232:45 pmRNSDealings in securities on behalf of ESIS
6th Apr 202310:30 amRNSForm 8.3 - [Mediclinic International plc]
5th Apr 202311:00 amRNSForm 8.3 - [Mediclinic International plc]
4th Apr 20232:00 pmRNSForm 8.3 - [Mediclinic International plc]
4th Apr 20231:00 pmRNSDealings in securities on behalf of ESOP
4th Apr 20239:00 amRNSOML BEE certificate and annual compliance report
31st Mar 20232:30 pmRNSDealings in Securities on behalf of Share Trusts
30th Mar 202312:15 pmRNSForm 8.3 - [Mediclinic International plc]
29th Mar 20232:30 pmRNSDealings in securities on behalf of share trusts
27th Mar 20234:15 pmRNSDealings in securities on behalf of a share trust
24th Mar 20237:00 amRNSNo change statement
22nd Mar 20238:00 amRNSFINALISATION AND DIVIDEND CURRENCY EQUIVALENTS
17th Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20233:15 pmRNSDealings in securities on behalf of share trusts
17th Mar 202312:30 pmRNSForm 8.3 - Mediclinic International plc
16th Mar 202310:30 amRNSForm 8.3 - [Mediclinic International plc]
15th Mar 202312:30 pmRNSForm 8.3 - [Mediclinic International plc]
14th Mar 20231:30 pmRNSForm 8.3 - [Mediclinic International plc]
14th Mar 20237:00 amRNSFinal Results
10th Mar 202311:00 amRNSForm 8.3 - Mediclinic International plc
9th Mar 202311:00 amRNSForm 8.3 - Mediclinic International plc
8th Mar 202312:30 pmRNSForm 8.3 - Mediclinic International plc
3rd Mar 202310:00 amRNSForm 8.3 - [Mediclinic International plc]
2nd Mar 202312:00 pmRNSForm 8.3 - [Mediclinic International plc]
24th Feb 20237:00 amRNSVoluntary Trading Statement
23rd Feb 20237:00 amRNSDirector/PDMR Shareholding Correction
22nd Feb 20233:30 pmRNSDirector/PDMR Shareholding
7th Feb 202312:00 pmRNSForm 8.3 - [Mediclinic International plc]
3rd Feb 20231:00 pmRNSForm 8.3 - [Mediclinic International plc]
27th Jan 20231:30 pmRNSForm 8.3 - [Mediclinic International plc]
10th Jan 202311:30 amRNSForm 8.3 - [Mediclinic International plc]
5th Jan 202312:00 pmRNSForm 8.3 - Mediclinic International plc
21st Dec 20221:00 pmRNSForm 8.3 - [Mediclinic International plc]
16th Dec 20221:00 pmRNSForm 8.3 - Mediclinic International plc
15th Dec 20221:50 pmRNSForm 8.3 - Mediclinic International plc
15th Dec 202211:30 amRNSForm 8.3 - Micro Focus International plc
30th Nov 202212:00 pmRNSForm 8.3 - Mediclinic International plc
22nd Nov 20227:00 amRNSVoluntary Operating Update
21st Nov 20223:00 pmRNSImplementation of the Bula Tsela transaction
18th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
17th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
16th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.